Article Detail - JE Part B
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R11 - Effective October 01, 2023
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (HI and Territories), and 01312 (NV).
Effective Date: October 01, 2023
Summary of Article Changes: Under CPT/HCPCS Group 1: Codes added 0411U and 0419U. This revision is due to the 2023 Q4 CPT/HCPCS Code Update and is effective on October 1, 2023.
Under Article Text revised Table 2 to delete row for CFTR as this is not relevant to the general Medicare population. Under subheading Covered multigene panels with intended uses revised verbiage to read "Panels with a specific intended use such as major depressive disorder (MDD) or neuropsychiatric must include relevant ICD-10 codes." and deleted Table 3. Under CPT/HCPCS Codes Group 1: Codes deleted 81220. This revision is effective on October 1, 2023.
Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.
